Article: Barr Laboratories Inc.(In other generics news)(drug approval for Dostinex)(Brief article)

Article: Agvar Chemicals Sues Barr Laboratories, Teva ...
PR Newswire;  October 11, 2005 ;     700+ words ... ... Ranbaxy Laboratories Limited and Ranbaxy Pharmaceuticals, Inc. as plaintiffs in a lawsuit against Barr Laboratories, Inc. and Teva Pharmaceuticals USA, Inc. for damages and equitable relief for breach of contract, fraud and tortious interference ...

Article: Barr, teva reap benefits of successful generic blockbusters. ...
Drug Store News;  November 19, 2001 ;     700+ words ...NEW YORK -- Generic drug makers Barr Laboratories and Teva USA both reported satisfaction with recent ... s Premarin. Teva 'S generic Rocaltrol approved Teva Pharmaceuticals, which reported net income of $79 million for its ...

Article: Ranbaxy Files Suit Against Barr Laboratories and ...
PR Newswire;  October 11, 2005 ;     700+ words ... ... announced today that, along with Agvar Chemicals Inc., they have filed a joint complaint against Barr Laboratories, Inc. and Teva Pharmaceuticals, USA Inc. for damages and equitable relief for breach of contract, fraud and tortious interference ...

Article: AMRI Announces Agreement with Teva Pharmaceuticals ...
Business Wire;  November 19, 2008 ;     700+ words ... ... S. LLC, Teva Pharmaceuticals, USA, Inc. and Barr Laboratories, Inc. The ... D-12to Teva Pharmaceuticals, USA, Inc. and Barr Laboratories, Inc. in ... 12) by Teva Pharmaceuticals, USA, Inc. and Barr Laboratories, Inc. through ...

Article: AMRI Files Patent Infringement Lawsuits Against Barr ...
Business Wire;  March 10, 2004 ;     700+ words ... ... Aventis Pharmaceuticals, Inc., has filed patent infringement actions against Barr Laboratories, Inc., Mylan Pharmaceuticals, Inc., Teva Pharmaceuticals, USA, Inc., Impax Laboratories, Inc., Dr. Reddy's Laboratories, Ltd ...

Article: Sepracor Announces Final Settlement of XOPENEX[R] Inhalation ...
Business Wire;  March 10, 2009 ;     700+ words ... ... SEPR) today announced that it has entered into a Settlement and License Agreement with Teva Pharmaceuticals USA, Inc. (Teva) and Barr Laboratories, Inc. (Barr), a wholly owned subsidiary of Teva, to resolve the patent litigation ...

Article: Mumbai, Oct 13 (PTI) Pharmaceutical major Ranbaxy Laboratories ...
PTI - The Press Trust of India Ltd.;  October 13, 2005 ;     626 words ...Ranbaxy Pharmaceuticals Inc. Along with Agvar Chemicals Inc. Has filed the complaint also for fraud and tortious interference associated with the supply of Active Pharmaceutical Ingredients regarding the commercialisation of fexofenadine hydrochloride tablets, RLL informed Bombay Stock Exchange.